MarketInOut Stock Screener Log In | Sign Up
 

Insulet Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 06/26/2026 16:00
Insulet Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9,967.19 mln
Float68.99 mln
Earnings Date08/06/2026

EPS

4.28
Stretched

P / E

36.97
Overvalued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.47
Borderline

1-Year Forecast

242
Exceptional upside

Relative Strength

83 / 100
Strongly outperforming

Business Description

Insulet Corporation designs and sells wearable insulin delivery devices for people living with insulin-dependent diabetes, serving customers across the United States and in markets around the world. The company is best known for its Omnipod product line, which offers tubeless, hands-free alternatives to traditional insulin pumps, including systems that automatically adjust insulin delivery by communicating wirelessly with glucose monitors. Beyond diabetes care, Insulet also supplies delivery pods used in a medical kit that helps protect cancer patients from infection following chemotherapy. Founded in 2000 and based in Acton, Massachusetts, the company reaches customers through pharmacies and distribution partners.

Key Fundamentals

EPS4.28
P/E36.97
ROE21.64
RPS41.12
ROIC19.65
ROA9.35
Interest Cover7.83
EBITDA, mln532
EV / EBITDA19.44
EV / EBIT22.32
Revenue, mln2,901
EV / Revenue3.57

Financial Strength

Altman Z-Score5.68
Piotroski F-Score 6 / 9
Beneish M-Score-2.47
Price to Intrinsic Value4.75
Price to Lynch Fair Value1.07
Price to Graham Number3.23
1-Year Target Price242
Shiller PE Ratio101
Short Ratio2.20
Short % of Float6.90

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.57% 91 / 100   
1 Month 8.38% 84 / 100   
2 Months -30.78% 10 / 100   
6 Months -44.57% 12 / 100   
1 Year -48.32% 14 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us